Contineum Therapeutics Market Sentiment

Contineum Therapeutics Inc

CTNMNASDAQ

Trade with Public

$13.38

0.201.52%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Contineum Therapeutics Market Sentiment - Benzinga

Contineum Therapeutics Market Sentiment

Market sentiment signals for Contineum Therapeutics (CTNM): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 9.4% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Outperform

6 analysts

Options Flow (P/C)

—

Avg Consensus PT

$22

+64.4%

Highest Price Target

$29

+116.7%

Stifel

Lowest Price Target

$17

+27.1%

Morgan Stanley

Short Interest

9.4%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 28, 2026	Morgan Stanley	Jeffrey Hung—	+27.1%	$18 → $17	Maintained	Equal-Weight
Sep 15, 2026	Jones Trading	Debanjana Chatterjee—	+79.4%	$26 → $24	Maintained	Buy
Sep 15, 2026	Baird	Joel Beatty—	+42.0%	$20 → $19	Maintained	Outperform
Jul 31, 2026	RBC Capital	Brian Abrahams—	+71.9%	$22 → $23	Maintained	Outperform
May 14, 2026	Morgan Stanley	Jeffrey Hung—	+19.6%	$14 → $16	Maintained	Equal-Weight
Mar 6, 2026	Baird	Joel Beatty—	+49.5%	$14 → $20	Maintained	Outperform
Jan 8, 2026	Morgan Stanley	Jeffrey Hung—	+4.6%	$23 → $14	Downgrade	Overweight→Equal-Weight
Nov 24, 2025	Baird	Joel Beatty—	+4.6%	$16 → $14	Maintained	Outperform
Nov 21, 2025	RBC Capital	Brian Abrahams—	+64.4%	$25 → $22	Maintained	Outperform
Sep 25, 2025	Leerink Partners	Faisal Khurshid—	+49.5%	$20	Initiate	Outperform
Aug 18, 2025	Morgan Stanley	Jeffrey Hung—	+57.0%	$20 → $21	Maintained	Overweight
May 19, 2025	Morgan Stanley	Jeffrey Hung—	+49.5%	$25 → $20	Maintained	Overweight
May 15, 2025	RBC Capital	Brian Abrahams—	+131.7%	$31 → $31	Maintained	Outperform
Mar 13, 2025	Jones Trading	Debanjana Chatterjee—	+71.9%	$23	Initiate	Buy
Mar 7, 2025	Morgan Stanley	Jeffrey Hung—	+86.8%	$25 → $25	Assumes	Overweight
Mar 7, 2025	Baird	Joel Beatty—	+19.6%	$32 → $16	Maintained	Outperform
Jan 9, 2025	RBC Capital	Brian Abrahams—	+131.7%	$31 → $31	Maintained	Outperform
Nov 7, 2024	RBC Capital	Brian Abrahams—	+131.7%	$32 → $31	Maintained	Outperform
Oct 22, 2024	Baird	Joel Beatty—	+139.2%	$32	Initiate	Outperform
Aug 14, 2024	RBC Capital	Brian Abrahams—	+139.2%	$30 → $32	Maintained	Outperform
Apr 30, 2024	Stifel	Paul Matteis—	+116.7%	$29	Initiate	Buy
Apr 30, 2024	RBC Capital	Brian Abrahams—	+124.2%	$30	Initiate	Outperform
Apr 30, 2024	Morgan Stanley	Jeffrey Hung—	+86.8%	$25	Initiate	Overweight

More with Benzinga EdgeGet Access

Contineum Therapeutics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Contineum Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch